These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21881118)

  • 1. Genetic variants and susceptibility to neurological complications following West Nile virus infection.
    Loeb M; Eskandarian S; Rupp M; Fishman N; Gasink L; Patterson J; Bramson J; Hudson TJ; Lemire M
    J Infect Dis; 2011 Oct; 204(7):1031-7. PubMed ID: 21881118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis.
    Cahill ME; Conley S; DeWan AT; Montgomery RR
    BMC Infect Dis; 2018 Jun; 18(1):282. PubMed ID: 29929468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.
    Yakub I; Lillibridge KM; Moran A; Gonzalez OY; Belmont J; Gibbs RA; Tweardy DJ
    J Infect Dis; 2005 Nov; 192(10):1741-8. PubMed ID: 16235172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.
    Rios JJ; Fleming JG; Bryant UK; Carter CN; Huber JC; Long MT; Spencer TE; Adelson DL
    PLoS One; 2010 May; 5(5):e10537. PubMed ID: 20479874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
    Lim JK; Lisco A; McDermott DH; Huynh L; Ward JM; Johnson B; Johnson H; Pape J; Foster GA; Krysztof D; Follmann D; Stramer SL; Margolis LB; Murphy PM
    PLoS Pathog; 2009 Feb; 5(2):e1000321. PubMed ID: 19247438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein.
    Lucas M; Mashimo T; Frenkiel MP; Simon-Chazottes D; Montagutelli X; Ceccaldi PE; Guénet JL; Desprès P
    Immunol Cell Biol; 2003 Jun; 81(3):230-6. PubMed ID: 12752688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host genetic risk factors for West Nile virus infection and disease progression.
    Bigham AW; Buckingham KJ; Husain S; Emond MJ; Bofferding KM; Gildersleeve H; Rutherford A; Astakhova NM; Perelygin AA; Busch MP; Murray KO; Sejvar JJ; Green S; Kriesel J; Brinton MA; Bamshad M
    PLoS One; 2011; 6(9):e24745. PubMed ID: 21935451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term neurological outcomes in West Nile virus-infected patients: an observational study.
    Weatherhead JE; Miller VE; Garcia MN; Hasbun R; Salazar L; Dimachkie MM; Murray KO
    Am J Trop Med Hyg; 2015 May; 92(5):1006-1012. PubMed ID: 25802426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [OAS genes and susceptibility to West Nile virus].
    Guénet JL; Després P
    Med Sci (Paris); 2003 Jan; 19(1):9-12. PubMed ID: 12836183
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease.
    Long D; Deng X; Singh P; Loeb M; Lauring AS; Seielstad M
    Genes Immun; 2016 Jul; 17(5):298-304. PubMed ID: 27170560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus and host determinants of West Nile virus pathogenesis.
    Diamond MS
    PLoS Pathog; 2009 Jun; 5(6):e1000452. PubMed ID: 19557199
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.
    Graham JB; Thomas S; Swarts J; McMillan AA; Ferris MT; Suthar MS; Treuting PM; Ireton R; Gale M; Lund JM
    mBio; 2015 May; 6(3):e00493-15. PubMed ID: 25944860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetic variability and West Nile virus susceptibility.
    Samuel CE
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11555-7. PubMed ID: 12192094
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic variants associated with susceptibility of Ashkenazi Jews to West Nile virus infection.
    Danial-Farran N; Eghbaria S; Schwartz N; Kra-Oz Z; Bisharat N
    Epidemiol Infect; 2015 Mar; 143(4):857-63. PubMed ID: 24865988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis.
    Simon-Chazottes D; Frenkiel MP; Montagutelli X; Guénet JL; Desprès P; Panthier JJ
    Virology; 2011 Aug; 417(1):147-53. PubMed ID: 21683973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.
    Barkhash AV; Perelygin AA; Babenko VN; Myasnikova NG; Pilipenko PI; Romaschenko AG; Voevoda MI; Brinton MA
    J Infect Dis; 2010 Dec; 202(12):1813-8. PubMed ID: 21050126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA.
    Weber IB; Lindsey NP; Bunko-Patterson AM; Briggs G; Wadleigh TJ; Sylvester TL; Levy C; Komatsu KK; Lehman JA; Fischer M; Staples JE
    Epidemiol Infect; 2012 Sep; 140(9):1632-6. PubMed ID: 22123531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
    Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
    Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic basis for human susceptibility to West Nile virus.
    Diamond MS; Klein RS
    Trends Microbiol; 2006 Jul; 14(7):287-9. PubMed ID: 16750369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.
    Lim JK; Louie CY; Glaser C; Jean C; Johnson B; Johnson H; McDermott DH; Murphy PM
    J Infect Dis; 2008 Jan; 197(2):262-5. PubMed ID: 18179388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.